Global Lyme Borreliosis Treatment Market - Industry Trends and Forecast to 2028

Market Analysis and Insights: Global Lyme Borreliosis Treatment Market

Lyme borreliosis treatment market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 3.80% in the above mentioned forecast period.

Lyme borreliosis is a bacterial infection which is also known as lyme disease and caused by the bacteria Borrelia burgdorferi., and B. burgdorferi. The bacterium is transmitted through the bite of an infected black-legged or deer tick. The tick at least takes 32 hour to transmit the infection and it present on the skin. Tick gets infected after feeding on infected deer, mice or birds. The symptoms of this disorder are muscle aches, joint pain, swelling, fever, swollen lymph nodes, headache, sleep disturbances, fatigue, difficulty concentrating and skin rashes.

Rise in the prevalence of lyme borreliosis, growing healthcare expenditure and growing demand for effective treatment are the major drivers influencing the market growth rate. Furthermore, growing government funding, rising initiatives by government and private organizations to spread awareness for animal care and harms of lyme borreliosis are the factors that will expand the lyme borreliosis treatment market.

Rise in the investment for research and development activities and emerging markets will provide beneficial opportunities for the lyme borreliosis treatment market in the forecast period of 2021-2028.

However, high cost of treatment and surge in the number of generic products are the factors that will hinder the market growth. In the forecast period mentioned above, lack of awareness about tick-borne diseases will challenge the lyme borreliosis treatment market.

This lyme borreliosis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lyme borreliosis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Lyme Borreliosis Treatment Market Scope and Market Size

The lyme borreliosis treatment market is segmented on the basis of type of bacteria, disease type, treatment, diagnosis, dosage, route of administration, application, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type of bacteria, the lyme borreliosis treatment market is segmented into borrelia afzelii, borrelia mayonii, borrelia garinii, borrelia burgdorferi and others.
• On the basis of disease type, the lyme borreliosis treatment market is segmented into early lyme disease, lyme arthritis, neurologic lyme disease, borrelial lymphocytosis, post-treatment lyme disease syndrome (PTLDS) and lyme carditis.
• On the basis of treatment, the lyme borreliosis treatment market is segmented into antibiotics, non-steroidal anti-inflammatory drugs (NSAIDS), tick removal and others. Antibiotics have been further sub-segmented into tetracycline, cephalosporin, macrolides and others.
• On the basis of diagnosis, the lyme borreliosis treatment market is segmented into enzyme-linked immunosorbent assay (ELISA) test, western blot test and others.
• On the basis of dosage, the lyme borreliosis treatment market is segmented into tablet, injection, ointment and others.
• On the basis of route of administration, the lyme borreliosis treatment market is segmented into oral, injectable, topical and others.
• On the basis of application, the lyme borreliosis treatment market is segmented into human and animals.
• On the basis of symptoms, the lyme borreliosis treatment market is segmented into muscle aches, joint pain, swelling, fever, swollen lymph nodes, headache, sleep disturbances, fatigue, difficulty concentrating and others.
• On the basis of end-users, the lyme borreliosis treatment market is segmented into clinic, hospital and others.

The lyme borreliosis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Lyme Borreliosis Treatment Market Country Level Analysis

Lyme borreliosis treatment market is analyzed and market size information is provided by the country, type of bacteria, disease type, treatment, diagnosis, dosage, route of administration, application, symptoms, end-users and distribution channel as referenced above.

The countries covered in the lyme borreliosis treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the lyme borreliosis treatment market due to major key players, growing investment for R&D activities, high disposable income, high healthcare expenditure, and a well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare infrastructure and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Lyme borreliosis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Lyme Borreliosis Treatment Market Share Analysis

Lyme borreliosis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to lyme borreliosis treatment market research.

The major players covered in the lyme borreliosis treatment market report are Allergan, Merck Sharp & Dohme Corp., Pfizer Inc., GlaxoSmithKline plc, Melinta Therapeutics LLC, Basilea Pharmaceutica Ltd., Tetraphase Pharmaceuticals, Paratek Pharmaceuticals, Inc., Nabriva Therapeutics plc, Spero Therapeutics, Abbott, F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Bayer AG, Sun Pharmaceutical Industries Ltd., Eli Lilly and Company, Aurobindo Pharma, Lupin, SHIONOGI & Co., Ltd., AbbVie Inc., Cumberland Pharmaceuticals Inc., among other domestic and global players.  Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-66822